This report contains market size and forecasts of Sepsis Diagnostics Testing in Global, including the following market information:
Global Sepsis Diagnostics Testing Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Sepsis Diagnostics Testing market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Point-of-Care Testing Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Sepsis Diagnostics Testing include Abbott, Axis Shield, Becton Dickinson, bioM?rieux, Bruker, Cytosorbents, Danaher, Immunexpress and Luminex, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
Publisher has surveyed the Sepsis Diagnostics Testing companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Sepsis Diagnostics Testing Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Sepsis Diagnostics Testing Market Segment Percentages, by Type, 2021 (%)
Point-of-Care Testing
Laboratory Testing
Global Sepsis Diagnostics Testing Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Sepsis Diagnostics Testing Market Segment Percentages, by Application, 2021 (%)
General Hospitals
Specialty Clinics
Global Sepsis Diagnostics Testing Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Sepsis Diagnostics Testing Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Sepsis Diagnostics Testing revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Sepsis Diagnostics Testing revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Abbott
Axis Shield
Becton Dickinson
bioM?rieux
Bruker
Cytosorbents
Danaher
Immunexpress
Luminex
Mitsubishi Chemical
Response Biomedical
Roche
T2 Biosystems
Thermo Fisher Scientific
Table of Contents
1 Introduction to Research & Analysis Reports
1.1 Sepsis Diagnostics Testing Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Sepsis Diagnostics Testing Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Sepsis Diagnostics Testing Overall Market Size
2.1 Global Sepsis Diagnostics Testing Market Size: 2021 VS 2028
2.2 Global Sepsis Diagnostics Testing Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Sepsis Diagnostics Testing Players in Global Market
3.2 Top Global Sepsis Diagnostics Testing Companies Ranked by Revenue
3.3 Global Sepsis Diagnostics Testing Revenue by Companies
3.4 Top 3 and Top 5 Sepsis Diagnostics Testing Companies in Global Market, by Revenue in 2021
3.5 Global Companies Sepsis Diagnostics Testing Product Type
3.6 Tier 1, Tier 2 and Tier 3 Sepsis Diagnostics Testing Players in Global Market
3.6.1 List of Global Tier 1 Sepsis Diagnostics Testing Companies
3.6.2 List of Global Tier 2 and Tier 3 Sepsis Diagnostics Testing Companies
4 Market Sights by Product
4.1 Overview
4.1.1 by Type - Global Sepsis Diagnostics Testing Market Size Markets, 2021 & 2028
4.1.2 Point-of-Care Testing
4.1.3 Laboratory Testing
4.2 By Type - Global Sepsis Diagnostics Testing Revenue & Forecasts
4.2.1 By Type - Global Sepsis Diagnostics Testing Revenue, 2017-2022
4.2.2 By Type - Global Sepsis Diagnostics Testing Revenue, 2023-2028
4.2.3 By Type - Global Sepsis Diagnostics Testing Revenue Market Share, 2017-2028
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Sepsis Diagnostics Testing Market Size, 2021 & 2028
5.1.2 General Hospitals
5.1.3 Specialty Clinics
5.2 By Application - Global Sepsis Diagnostics Testing Revenue & Forecasts
5.2.1 By Application - Global Sepsis Diagnostics Testing Revenue, 2017-2022
5.2.2 By Application - Global Sepsis Diagnostics Testing Revenue, 2023-2028
5.2.3 By Application - Global Sepsis Diagnostics Testing Revenue Market Share, 2017-2028
6 Sights by Region
6.1 By Region - Global Sepsis Diagnostics Testing Market Size, 2021 & 2028
6.2 By Region - Global Sepsis Diagnostics Testing Revenue & Forecasts
6.2.1 By Region - Global Sepsis Diagnostics Testing Revenue, 2017-2022
6.2.2 By Region - Global Sepsis Diagnostics Testing Revenue, 2023-2028
6.2.3 By Region - Global Sepsis Diagnostics Testing Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country - North America Sepsis Diagnostics Testing Revenue, 2017-2028
6.3.2 US Sepsis Diagnostics Testing Market Size, 2017-2028
6.3.3 Canada Sepsis Diagnostics Testing Market Size, 2017-2028
6.3.4 Mexico Sepsis Diagnostics Testing Market Size, 2017-2028
6.4 Europe
6.4.1 By Country - Europe Sepsis Diagnostics Testing Revenue, 2017-2028
6.4.2 Germany Sepsis Diagnostics Testing Market Size, 2017-2028
6.4.3 France Sepsis Diagnostics Testing Market Size, 2017-2028
6.4.4 U.K. Sepsis Diagnostics Testing Market Size, 2017-2028
6.4.5 Italy Sepsis Diagnostics Testing Market Size, 2017-2028
6.4.6 Russia Sepsis Diagnostics Testing Market Size, 2017-2028
6.4.7 Nordic Countries Sepsis Diagnostics Testing Market Size, 2017-2028
6.4.8 Benelux Sepsis Diagnostics Testing Market Size, 2017-2028
6.5 Asia
6.5.1 By Region - Asia Sepsis Diagnostics Testing Revenue, 2017-2028
6.5.2 China Sepsis Diagnostics Testing Market Size, 2017-2028
6.5.3 Japan Sepsis Diagnostics Testing Market Size, 2017-2028
6.5.4 South Korea Sepsis Diagnostics Testing Market Size, 2017-2028
6.5.5 Southeast Asia Sepsis Diagnostics Testing Market Size, 2017-2028
6.5.6 India Sepsis Diagnostics Testing Market Size, 2017-2028
6.6 South America
6.6.1 By Country - South America Sepsis Diagnostics Testing Revenue, 2017-2028
6.6.2 Brazil Sepsis Diagnostics Testing Market Size, 2017-2028
6.6.3 Argentina Sepsis Diagnostics Testing Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Sepsis Diagnostics Testing Revenue, 2017-2028
6.7.2 Turkey Sepsis Diagnostics Testing Market Size, 2017-2028
6.7.3 Israel Sepsis Diagnostics Testing Market Size, 2017-2028
6.7.4 Saudi Arabia Sepsis Diagnostics Testing Market Size, 2017-2028
6.7.5 UAE Sepsis Diagnostics Testing Market Size, 2017-2028
7 Players Profiles
7.1 Abbott
7.1.1 Abbott Corporate Summary
7.1.2 Abbott Business Overview
7.1.3 Abbott Sepsis Diagnostics Testing Major Product Offerings
7.1.4 Abbott Sepsis Diagnostics Testing Revenue in Global Market (2017-2022)
7.1.5 Abbott Key News
7.2 Axis Shield
7.2.1 Axis Shield Corporate Summary
7.2.2 Axis Shield Business Overview
7.2.3 Axis Shield Sepsis Diagnostics Testing Major Product Offerings
7.2.4 Axis Shield Sepsis Diagnostics Testing Revenue in Global Market (2017-2022)
7.2.5 Axis Shield Key News
7.3 Becton Dickinson
7.3.1 Becton Dickinson Corporate Summary
7.3.2 Becton Dickinson Business Overview
7.3.3 Becton Dickinson Sepsis Diagnostics Testing Major Product Offerings
7.3.4 Becton Dickinson Sepsis Diagnostics Testing Revenue in Global Market (2017-2022)
7.3.5 Becton Dickinson Key News
7.4 bioM